ECB Rate Hikes Could Be Big Mistake Amid Stagflation Risks Berenberg Economist Warns US REIT MA Shift PublictoPublic Consolidation Takes the Lead Alibaba Unveils NextGeneration Zhenwu AI Chip and Large Language Model to Bolster Cloud AI Portfolio Pope Leos Encyclical on AI Draws Ethical Lines as Anthropic Attends Signing ConocoPhillips A Potential Natural Hedge Amid Economic Uncertainty AnheuserBusch InBev Shares Slide on Missed Sales Estimates Armstrong World Industries Q1 2026 Earnings EPS Falls Short of Estimates Stock Inches Lower UnitedGuardian Inc UG Q2 2025 Earnings Positive EPS of 014 Highlights Steady Performance ATLCP Q1 2026 Earnings EPS Surges Past Estimates as Profitability Strengthens CSX Q1 2026 Earnings EPS Surprise Drives Profit Beat but Stock Declines Arbe Robotics Q4 2025 Earnings Narrowing Losses Amidst Market Skepticism Novagold Resources NG Q1 2026 Earnings Narrower Loss Surpasses Estimates Amid Precious Metals Focus Alpha Teknova TKNO Edges Higher Amid RangeBound Trading Key Levels in Focus AREN Gains 227 as Support Holds Arena Group Tests Key Resistance Matador Resources MTDR Slips 24 as Energy Sector Headwinds Mount Lovesac LOVE Edges Higher as Stock Holds Above Key Support at 1558 Kura Oncology KURA Slips 244 as Shares Approach Key Support Zone Quantinuum Files for IPO Quantum Computing Startup Targets 13 Billion Valuation CIEN Q1 2026 Earnings Strong EPS Beat Despite Revenue Uncertainty Moving iMage Technologies MITQ Holds Steady at 060 as Trading Range Tightens Fed Holds Rates Steady as Powell Era Winds Down Fed Holds Rates Steady for Third Straight Meeting Powell Affirms Commitment to Remain as Chair Enhanced Games Donald Trump JrBacked Steroid Olympics Set for Sunday Debut Amid Product Expansion Plans Bond Market Eyes Policy Shift as Warsh Assumes Fed Leadership Amid Inflation Concerns CNBC Portfolio Manager Takes Profits on Stock That Rose 46 in One Week 80 Since April Retail Investors Gain Direct Access to SpaceX IPO Through Major Brokerage Platforms Tony Blairs Economic Diagnosis Hits Mark but AIFocused Prescription Draws Skepticism